| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/05/2008 | US7326534 Detection of gleevec resistant mutations |
| 02/05/2008 | US7326531 Proteases from gram-positive organisms |
| 02/05/2008 | US7326529 Using cancer specific genes |
| 02/05/2008 | US7326419 Membrane proteins or polypeptides, used as vaccines or for medical diagnosis |
| 02/05/2008 | US7326418 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK |
| 02/05/2008 | US7326417 IGF-1 as feline vaccine adjuvant, in particular against feline retroviruses |
| 02/05/2008 | US7326416 Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1(INI1)/hSNF5 |
| 02/05/2008 | US7326415 derived from epithelial cells and malignant lymphoma; also for irritable bowel syndrome, viral and other infections; genetic engineering; kits |
| 02/05/2008 | US7326413 Antibodies against the PRO1434 polypeptide |
| 02/05/2008 | US7326411 Use of amino-terminally truncated RANTES to inhibit HIV viral replication |
| 02/05/2008 | US7325603 Methods of well treatment |
| 02/05/2008 | CA2348240C Transcriptional activator lec1 nucleic acids, polypeptides and their uses |
| 02/05/2008 | CA2283597C Reduced cortisol conjugates |
| 02/05/2008 | CA2225963C Transforming growth factor beta crystals |
| 02/05/2008 | CA2218161C Peptide compositions with growth factor-like activity |
| 02/05/2008 | CA2166155C Agents binding to hyaluronic acid binding domains and the use thereof |
| 02/05/2008 | CA2156255C Soluble thrombomodulin-containing composition |
| 02/05/2008 | CA2124953C Peptides related to prion proteins |
| 02/01/2008 | WO2007012188A1 GLP/1/EXENDM 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES |
| 02/01/2008 | CA2658673A1 Composition and method for prevention and treatment of type i and type ii diabetes |
| 01/31/2008 | WO2008014426A2 Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells |
| 01/31/2008 | WO2008014410A2 Zimlig2 polynucleotides and polypeptides and methods of use |
| 01/31/2008 | WO2008014382A2 System and method for controlling g-protein coupled receptor pathways |
| 01/31/2008 | WO2008013590A2 Implementation of a mitochondrial mutator |
| 01/31/2008 | WO2008013552A2 Fully human hybridoma fusion partner cell lines |
| 01/31/2008 | WO2008013329A1 Pas mutants and vectors carrying the same |
| 01/31/2008 | WO2008013324A1 Use of diabetes-related, liver-derived secreted protein in diagnosis or treatment of type-2 diabetes or vascular disorder |
| 01/31/2008 | WO2008013202A1 Application of fluorescent protein to horticultural plant |
| 01/31/2008 | WO2008013082A1 Galectin 9-polymer conjugate |
| 01/31/2008 | WO2008012941A1 Method for diagnosis of heart failure |
| 01/31/2008 | WO2008012689A2 Cytokine derivatives |
| 01/31/2008 | WO2008012629A2 Exendin fusion proteins |
| 01/31/2008 | WO2008012528A1 N-terminal polysialylation |
| 01/31/2008 | WO2008012525A1 Derivatisation of granulocyte colony-stimulating factor |
| 01/31/2008 | WO2008012505A2 Gpi-anchored cell surface glycoprotein |
| 01/31/2008 | WO2008012503A1 Homologue of pro4426 |
| 01/31/2008 | WO2008012362A2 New protein isoforms and uses thereof |
| 01/31/2008 | WO2008012296A1 Labelling of fusion proteins with synthetic probes |
| 01/31/2008 | WO2008012066A2 Novel peptide having antimicrobial activity |
| 01/31/2008 | WO2008012049A1 Post-translationally modified neurotrophins |
| 01/31/2008 | WO2008012045A2 Regulation of interleukin-23 |
| 01/31/2008 | WO2008011672A1 A cancer vaccine comprising a mucin 1 (muc1) t cell epitope-derived peptide |
| 01/31/2008 | WO2007137986A3 Vaccination against cancer |
| 01/31/2008 | WO2007135426A3 Treatment of neurodegeneratives diseases |
| 01/31/2008 | WO2007126392A8 Antimicrobial peptides |
| 01/31/2008 | WO2007119880A9 A method for producing an l-amino acid using a bacterium of the enterobacteriaceae family which has been modified to abolish curli formation |
| 01/31/2008 | WO2007053165A3 Virus protein microarray and uses therefor |
| 01/31/2008 | WO2006134195A8 Use of a cytokine from the interleukin-6 family in the preparation of a composition for combined administration with interferon-alpha |
| 01/31/2008 | WO2006134190A8 Agents and methods based on the use of the eda domain of fibronectin |
| 01/31/2008 | US20080028492 lyases enzymes obtained from transformed plant tissue expressing polynucleotide that encodes the polypeptide; improved ethanol biosynthesis, stalk and nodal strength |
| 01/31/2008 | US20080028480 Markers for Salinity Tolerance in Wheat Plants and the Use Thereof in Breeding Programs |
| 01/31/2008 | US20080027213 Chimeric immunogens |
| 01/31/2008 | US20080027148 Drug targets related to synthase subfamily; alternative splice forms; isolated peptides and antibodies |
| 01/31/2008 | US20080027147 polypeptides for use in the diagnosis and treatment of cell proliferative disorders |
| 01/31/2008 | US20080027145 Therapeutic Molecules and Methods for Generating and/or Selecting Same |
| 01/31/2008 | US20080027020 Human Neuropeptide Receptor |
| 01/31/2008 | US20080027005 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/31/2008 | US20080027004 Phosphorylated COP1 molecules and uses thereof |
| 01/31/2008 | US20080027002 Compositions and methods for targeting cancer-specific transcription complexes |
| 01/31/2008 | US20080027001 Nogo receptor functional motifs, peptide mimetics, and mutated functional motifs related thereto, and methods of using the same |
| 01/31/2008 | US20080027000 APO-A-I Regulation of T-Cell Signaling |
| 01/31/2008 | US20080026999 Dehydration, cyclization of peptide; prevention, therapy for bacteria infections; amino acid sequences |
| 01/31/2008 | US20080026998 Human kunitz-type inhibitor with enhanced antifibrinolytic activity |
| 01/31/2008 | US20080026996 Selective Vpac2 Receptor Reptide Agonists |
| 01/31/2008 | US20080026994 Modified vitamin K-dependent polypeptides |
| 01/31/2008 | US20080026993 Modified growth hormones |
| 01/31/2008 | US20080026992 Tyrosine Phosphorylation of Cdk Inhibitor Proteins of the Cip/Kip Family |
| 01/31/2008 | US20080026989 Human Ependymin |
| 01/31/2008 | US20080026985 Control of gene expression |
| 01/31/2008 | US20080026982 Mutant APOBEC3G molecules for inhibiting replication of HIV |
| 01/31/2008 | US20080026980 Use of Agents Derived from Ceacam1 for the Treatment of Inflammatory Diseases |
| 01/31/2008 | US20080026948 Protein (poly)peptides libraries |
| 01/31/2008 | US20080026467 Novel Agents for the Prevention of Leishmaniosis |
| 01/31/2008 | US20080026459 Differential expression via marker within genome; fluorescence activated cell sorting |
| 01/31/2008 | US20080026440 polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems having greater flexibility for commercial use; for the production of bioactive molecules of interest |
| 01/31/2008 | US20080026439 Pufa polyketide synthase systems and uses thereof |
| 01/31/2008 | US20080026438 Pufa polyketide synthase systems and uses thereof |
| 01/31/2008 | US20080026432 Novel L-Threonine Importer From Corynebacterium And A Preparation Method Of A Strain Producing L-Threonine |
| 01/31/2008 | US20080026427 HUMAN cDNAs AND PROTEINS AND USES THEREOF |
| 01/31/2008 | US20080026423 DEP-1 receptor protein tyrosine phosphatase interacting proteins and related methods |
| 01/31/2008 | US20080026422 Adding an desired amino acid analog to a medium containing a host cell with a vector coding for aminoacyl-tRNA synthetase and a vector coding for the polypeptide of interest; and growing the cell to produce the modified polypeptide |
| 01/31/2008 | US20080026421 Transgenic cells comprising peroxisomal membrane polypeptide (PMP) for transport of intracellular proteins to ouside of cell |
| 01/31/2008 | US20080026414 Method for the Determination of the Formation of Endothelins for Medical Diagnostic Purposes, and Antibodies and Kits for Carrying Out Such a Method |
| 01/31/2008 | US20080026404 G-protein coupled receptor for use in identifying modulators of taste perception in mammals; improving the palatability of low-calorie beverages |
| 01/31/2008 | US20080026403 Methods, Particles, and Kits for Determining Activity of a Kinase |
| 01/31/2008 | US20080026402 Hematopoietin receptors HPR1 and HPR2 |
| 01/31/2008 | US20080026399 treating bladder and lower urinary tract syndromes particularly irrative symptoms using alpha 1d-adrenergic receptor ( alpha 1dAR) antagonists; drug screening |
| 01/31/2008 | US20080026396 Method and nucleic acids for the analysis of astrocytomas |
| 01/31/2008 | US20080026384 Methods and compositions for the detection of bovine pregnancy |
| 01/31/2008 | US20080026376 KEX2 cleavage regions of recombinant fusion proteins |
| 01/31/2008 | US20080026127 Frozen Confectionery Product Comprising Ice Structuring Proteins |
| 01/31/2008 | US20080026077 Methods and compositions of gene delivery agents for systemic and local therapy |
| 01/31/2008 | US20080026072 glycoproteins having alpha 1,4-linked N-acetylglucosamine residue from milk of mammal containing carrier polypeptide with alpha 1,4-N-acetylglucosaminyl transferase; for treatment or prevention of gastric ulcers |
| 01/31/2008 | US20080026012 Recombinant cancer cell secreting modified heat shock protein-antigenic peptide complex |
| 01/31/2008 | US20080026011 Immunostimulatory nucleic acid molecules |
| 01/31/2008 | US20080026009 Borrelia burgdorferi bacterin |
| 01/31/2008 | US20080026007 Potentiation of the immune response |
| 01/31/2008 | US20080026000 Nicotine hapten where nicotine in which the pyrrolidine ring is substituted by an omega-carboxy-, -amino-, -formyl- or -mercapto-alkyl group; useful in formulating vaccines for active immunization; preventing nicotine addiction |
| 01/31/2008 | US20080025997 Cysteine-rich region of respiratory syncytial virus and methods of use therefor |
| 01/31/2008 | US20080025995 Cross-Placenta Delivery System |